Found 7 matching trials
GSK573719 IV Enabling Study PHASE1 A single-centre, open-label, sequential, cross-over study to examine the sa...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study to Determine the Excretion Balance and Pharmacokinetics of 14C-GSK573719 PHASE1 This will be a two-period, open-label study conducted at a single site. Six...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Pharmacokinetic, Safety, Tolerability, and Clinical Effect of Topical Umeclidinium in Primary Axillary Hyperhidrosis PHASE2 This is a double blind (sponsor unblind), repeat dose, randomized, parallel...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Characterization of Exposure From Topical Administration of [14C] Umeclidinium to Axilla or Palm of Healthy Male Subjects PHASE1 The purpose of this study is to characterize the pharmacokinetics (PK), saf...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Effectiveness of Fluticasone Furoate/ Umeclidinium/ Vilanterol (FF/UMEC/VI) Using the Connected Inhaler System (CIS) as Compared With Fluticasone Proprionate/ Salmeterol (FP/SAL) Plus Tiotropium (TIO) in Inadequately Controlled Asthma PHASE3 Asthma is a common, chronic respiratory disease affecting 1-18 percent of t...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate Clinical Effect, Pharmacokinetics , Safety, and Tolerability of Umeclidinium in Palmar Hyperhidrosis Subjects PHASE2 Umeclidinium (UMEC) is a potent pan-active long-acting muscarinic antagonis...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators PHASE4 The purpose of this study is to compare the effectiveness of inhaled bronch...
Show More Location
The University of Tennessee Graduate School of Medicine
Learn More & Join Trial